These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30541493)

  • 41. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
    Marin M; Patel M; Oberste S; Pallansch MA
    MMWR Morb Mortal Wkly Rep; 2017 Jan; 66(1):23-25. PubMed ID: 28081056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polio elimination in Nigeria: A review.
    Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM
    Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress toward poliomyelitis eradication--Nigeria, January 2004-July 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(35):873-7. PubMed ID: 16151372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015.
    Yehualashet YG; Mkanda P; Gasasira A; Erbeto T; Onimisi A; Horton J; Banda R; Tegegn SG; Ahmed H; Afolabi O; Wadda A; Vaz RG; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S116-23. PubMed ID: 26912379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
    Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global Polio Eradication Initiative Strategic Plan, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):107-8. PubMed ID: 14961005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polio eradication--target 2000.
    Gomber S; Agarwal KN
    Indian J Pediatr; 1996; 63(4):477-83. PubMed ID: 10832468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.
    Iliyasu Z; Verma H; Craig KT; Nwaze E; Ahmad-Shehu A; Jibir BW; Gwarzo GD; Gajida AU; Weldon WC; Steven Oberste M; Takane M; Mkanda P; Muhammad AJG; Sutter RW
    Vaccine; 2016 Sep; 34(42):5125-5131. PubMed ID: 27591950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E
    Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress towards polio eradication, Nigeria, 1996-1998.
    Wkly Epidemiol Rec; 1999 Apr; 74(16):121-4. PubMed ID: 10235052
    [No Abstract]   [Full Text] [Related]  

  • 53. Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
    Pons-Salort M; Molodecky NA; O'Reilly KM; Wadood MZ; Safdar RM; Etsano A; Vaz RG; Jafari H; Grassly NC; Blake IM
    PLoS Med; 2016 Oct; 13(10):e1002140. PubMed ID: 27701425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state, Nigeria.
    Nkwogu L; Shuaib F; Braka F; Mkanda P; Banda R; Korir C; Bawa S; Mele S; Saidu M; Mshelia H; Shettima A; Tegegne SG; Yehualashet YG; Adamu U; Nsubuga P; Vaz RG; Wondimagegnehu A
    BMC Public Health; 2018 Dec; 18(Suppl 4):1311. PubMed ID: 30541498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress Toward Poliomyelitis Eradication--Nigeria, January 2014-July 2015.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Ticha JM; Banda R; Korir C; Chevez AE; Enemaku O; Corkum M; Davis LB; Nganda GW; Burns CC; Wassilak SG; Vertefeuille JF
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(32):878-82. PubMed ID: 26292207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perspectives on polio and immunization in Northern Nigeria.
    Renne E
    Soc Sci Med; 2006 Oct; 63(7):1857-69. PubMed ID: 16765498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021.
    Mbaeyi C; Baig S; Khan Z; Young H; Kader M; Jorba J; Safdar MR; Jafari H; Franka R
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1359-1364. PubMed ID: 34591827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress Toward Poliomyelitis Eradication - Pakistan, January 2015-September 2016.
    Hsu CH; Mahamud A; Safdar RM; Ahmed J; Jorba J; Sharif S; Farag N; Martinez M; Tangermann RH; Ehrhardt D
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1295-1299. PubMed ID: 27880752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Musa A; Abba B; Ningi AM; Gali E; Bawa S; Manneh F; Mkanda P; Banda R; Yehuluashet YG; Tegegne SG; Umeh G; Nsubuga P; Etsano A; Shuaib F; Mohammed A; Vaz RG
    Vaccine; 2016 Oct; 34(43):5159-5163. PubMed ID: 27364095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Children who have received no routine polio vaccines in Nigeria: Who are they and where do they live?
    Uthman OA; Adedokun ST; Olukade T; Watson S; Adetokunboh O; Adeniran A; Oyetoyan SA; Gidado S; Lawoko S; Wiysonge CS
    Hum Vaccin Immunother; 2017 Sep; 13(9):2111-2122. PubMed ID: 28665749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.